Xalatan to delay glaucoma in patients with increased intraocular pressure

The reduction in intraocular pressure (IOP) is associated with far less risk of inducing glaucoma, which may cause blindness and loss of vision, according to a 5-year AccorOcular Hypertension Treatment Study (OHTS) of the U.S. National Ophthalmology Institute conducted by 22 hospitals in diverse races with different sex and age brackets and the clinical results was published in June issue of Op...